Food News and Research

RSS

Recent Africa Braintrust 2012 forum 'informative, inspiring' for those committed to continent's advancement

"Recently I attended the Africa Braintrust 2012 forum entitled 'Africa Rising: A Continent of Opportunity,' hosted by U.S. Rep. Karen Bass (D-Calif.) and the Congressional Black Caucus (CBC) as part of their Annual Legislative Conference, in Washington, D.C.," human rights activist Ivanley Noisette writes in the Huffington Post's "World" blog.

7 Nov 2012

FDA grants Priority Review to ImmunoGen’s trastuzumab emtansine BLA

ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Genentech, a member of the Roche Group, has disclosed that the U.S. Food and Drug Administration (FDA) has officially accepted the Biologics License Application (BLA) for trastuzumab emtansine and granted it Priority Review.

7 Nov 2012

FDA approves Pfizer’s XELJANZ to treat rheumatoid arthritis

Pfizer Inc. has received approval from the U.S. Food and Drug Administration (FDA) for XELJANZ (tofacitinib citrate) 5 mg twice daily for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate.

6 Nov 2012

NAI receives U.S. patent allowance for sustained release beta-alanine products

Natural Alternatives International, Inc., a leading formulator, manufacturer and marketer of customized nutritional supplements, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance of its patent application directed to sustained release formulations of beta-alanine.

6 Nov 2012

Pfizer receives FDA approval for Xeljanz to treat rheumatoid arthritis

The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate.

6 Nov 2012

Paragonix files PMNA with FDA for Sherpa Pak Cardiac Transport System

Paragonix Technologies, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its Paragonix Sherpa Pak Cardiac Transport System (CTS).

6 Nov 2012

Reducing malnutrition among refugees in South Sudan

"A combined effort by health, water, sanitation and nutrition partners, including the World Food Programme (WFP), to reduce alarming malnutrition rates amongst Sudanese refugees who have settled in Maban County of South Sudan, is beginning to yield fruit," WFP reports in an article on its webpage, adding, "Parents say they have seen dramatic improvements in their children's health."

6 Nov 2012

More calories consumed when eating out

Children and adolescents consume more calories and soda and have poorer nutrient-intake on days they eat at either fast-food or full-service restaurants, as compared to days they eat meals at -- or from -- home.

6 Nov 2012

Sorin Group’s Mitroflow Valsalva Conduit now available in the U.S.

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the U.S. commercial launch of the Mitroflow Valsalva Conduit, the only Valsalva conduit graft approved by the U.S. Food and Drug Administration (FDA) for use in combination with an aortic tissue valve.

6 Nov 2012

Leaders must continue to address food price volatility, food security

"Despite a sudden increase in July this year, prices of cereals on world markets remained fairly stable," Jose Graziano da Silva, director-general of the U.N. Food and Agriculture Organization (FAO), writes in an Inter Press Service opinion piece.

6 Nov 2012

Study examines role of friends in young women's body concerns

How women think their friends feel about their bodies influences their own body concerns, according to a new study by Dr. Louise Wasylkiw and Molly Williamson from Mount Alison University in Canada. Their work, which examines the role of friends in young women's body concerns, is published online in Springer's journal Sex Roles.

6 Nov 2012

Haiti faces rise in cholera cases after flooding caused by Hurricane Sandy

"Flooding in Haiti caused by Hurricane Sandy has triggered a surge in cholera, with three deaths and almost 300 suspected cases, adding to a death toll from the storm of 54," the Financial Times reports.

6 Nov 2012

Outcomes of state legislature races to play big role in health law's future

Although the race for the top of the ticket claims the biggest headlines, news outlets report that the winners of governor and state legislative races will have a major effect on the health law's implementation.

6 Nov 2012

Aid workers warn child nutrition reaching emergency levels in northern Mali

"Aid workers say child malnutrition is reaching emergency levels in northern Mali, which has been under the control of armed militant groups since April," VOA News reports. "Brussels-based aid organization Medecins du Monde, or Doctors of the World, says malnutrition rates among children under the age of five in occupied northern Mali are reaching 'alarming levels,'" the news service writes.

6 Nov 2012

Petition asks for expanded health benefits for superstorm Sandy first responders

Superstorm Sandy is still affecting the health care of the medically vulnerable in New York and New Jersey as a new petition calls for expanded health benefits for Sandy first responders.

6 Nov 2012

Frail older adults more likely to report food insufficiency

A national study of older Americans shows those who have limited mobility and low physical activity - scientifically categorized as "frail" - are five times more likely to report that they often don't have enough to eat, defined as "food insufficiency," than older adults who were not frail.

6 Nov 2012

Study: Superbug MRSA prevalent at wastewater treatment plants in the U.S.

A team led by researchers at the University of Maryland School of Public Health has found that the "superbug" methicillin-resistant Staphylococcus aureus (MRSA) is prevalent at several U.S. wastewater treatment plants (WWTPs).

6 Nov 2012

Endo, Bioniche decide to end second Urocidin Phase III trial on non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.

5 Nov 2012

Pradaxa use does not appear to increase serious bleeding

The U.S. Food and Drug Administration (FDA) today announced the results of a Mini-Sentinel assessment that indicates bleeding rates associated with new use of Pradaxa (dabigatran etexilate mesylate) capsules do not appear to be higher than bleeding rates associated with new use of warfarin, which is consistent with observations from the pivotal RE-LY trial.

4 Nov 2012